Advances in Diagnosis, Risk Stratification, and Personalized Management in Acute Coronary Syndromes

Dear Colleagues,

Cardiovascular disease (CVD) remains the leading cause of death worldwide, with acute coronary syndromes (ACSs) contributing significantly to this high mortality. In recent years, we have witnessed remarkable advancements in our understanding of ACS, from the unraveling of foundational mechanisms and clinical pathophysiology to the discovery of biomarkers that refine diagnosis and treatment. These developments have notably enhanced patient care and outcomes.

However, despite state-of-the-art management, significant residual risk persists, highlighting the need for continued innovations in ACS care. This Special Issue will gather cutting-edge research on prevention, timely diagnosis, risk assessment, and treatment strategies in ACS.

We welcome submissions addressing, but not limited to, the following topics:

• Novel diagnostic technologies and detection tools;
• Improved risk stratification methods, scores, and indices;
• Advances in clinical decision-making and personalized treatment approaches integrating genetics, biomarkers, and clinical data;
• Strategies for residual risk reduction and evaluations of long-term patient outcomes.

By showcasing these advancements, this Special Issue will provide invaluable insights for researchers and clinicians striving to enhance ACS prognosis and patient quality of life.

We look forward to reading your contributions.

Dr. Efstratios Karagiannidis
Dr. Barbara P. Fyntanidou
Dr. Aikaterini Apostolopoulou
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.